Global Intrauterine Devices Market

Global Intrauterine Devices Market Size Insights Forecasts to 2035

• The Global Intrauterine Devices Market Size Was valued at USD 4.6 Billion in 2024
• The Global Intrauterine Devices Market Size is Expected to Grow at a CAGR of around 3.89% from 2025 to 2035
• The Worldwide Intrauterine Devices Market Size is Expected to Reach USD 7.0 Billion by 2035
• North America is expected to grow the fastest during the forecast period.

According to a research report published by Decisions Advisors and Consulting, The Global Intrauterine Devices Market Size Was Worth Around USD 4.6 Billion In 2024 And Is Predicted To Grow To Around USD 7.0 Billion By 2035 With A Compound Annual Growth Rate (CAGR) Of 3.89% From 2025 To 2035. The market growth stems from increasing public understanding of long-acting reversible contraception (LARC) together with major progress in IUD design and insertion techniques and the government programs that support family planning and birth control access.

 

Market Overview

The Global Intrauterine Devices Market Size represents the international business sector which develops and produces and sells intrauterine contraceptive devices that enable women to achieve extended reversible birth control and to maintain their reproductive health. Additionally, technological developments in technology are leading to a better safety, efficacy, and user comfort. The modern IUDs use their dedicated insertion systems together with their compact flexible frames to reduce patient discomfort during the insertion process which helps prevent device expulsion and perforation. The IUD insertion procedure improvements result in higher consumer confidence and better customer satisfaction according to research findings. The IUD market shows positive trends because hormonal IUDs with lower hormone doses and longer-lasting effects provide women with more customized contraceptive options and reduced side effects.

 

Report Coverage

This research report categorizes the intrauterine devices market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the intrauterine devices market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the intrauterine devices market. 

 

Driving Factors

The Global Intrauterine Devices Market Size experiences its main growth drivers from three factors which include the rising need for long-term reversible contraceptive methods and the better understanding of family planning and the increased funding for healthcare services. Government initiatives that support reproductive health through subsidized contraceptive programs and public awareness campaigns in the United States and India allow better access to affordable birth control solutions for women which drives market expansion.

 

Restraining Factors

The Global Intrauterine Devices Market Size operational capacities throughout its entirety experience limitations which stem from various factors including side-effect concerns and risk of complications and restricted knowledge of the product and cultural obstacles and uneven healthcare distribution and high initial costs in particular areas.

 

Market Segmentation

The intrauterine devices market share is classified into type and distribution channel.

 

• The hormonal IUD segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.           

Based on the type, the intrauterine devices market is divided into hormonal IUD and copper IUD. Among these, the hormonal IUD segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The growth of the product results from its ability to prevent pregnancy and its additional benefits which include decreased menstrual bleeding and better menstrual symptom control and its benefits which users are now starting to learn about. Healthcare providers recommend hormonal IUDs because they provide two advantages which include birth control and relief from menstrual symptoms. The combination of new technological developments and ongoing product innovations draws consumers who want to access the newest and most effective solutions.          

• The hospital segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.     

Based on the distribution channel, the intrauterine devices market is divided into hospital, gynecology clinics, community health care centers, and others. Among these, the hospital segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The higher IUD usage results from its effective performance and extended birth control duration which hospitals use to deliver complete family planning services that include both counseling and insertion procedures. The hospital system benefits from improved service delivery because it has increased IUD insurance coverage and employs staff members who possess specialized training in IUD management.    

 

Regional Segment Analysis of the Intrauterine Devices Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

Asia Pacific is anticipated to hold the largest share of the intrauterine devices market over the predicted timeframe.

Asia Pacific is anticipated to hold the largest share of the intrauterine devices market over the predicted timeframe. The market will grow because of four factors which include the rising population growth the need for effective contraception and the government family planning initiatives and the development of healthcare facilities. The market will expand because people now understand and accept modern contraception methods together with women's empowerment and urban development and shifts in their daily activities.

 

North America is expected to grow at a rapid CAGR in the intrauterine devices market during the forecast period. The U.S. market is expanding because long-acting reversible contraceptives receive greater acceptance from customers. The market for hormonal IUDs has become the leading segment because these devices offer both high success rates and the additional advantage of reduced menstrual bleeding. New products are being developed that use softer materials and upgraded applicators to improve user experience during device insertion. The implementation of public health programs together with enhanced training opportunities for healthcare providers helps more IUDs to be used by different age groups.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the intrauterine devices market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• AbbVie Inc.
• Bayer AG
• CooperSurgical Inc.
• DKT International
• EUROGINE, S.L.
• Mona Lisa N.V.
• OCON Medical Ltd.
• Pregna International Limited.
• Prosan International BV
• SMB Corporation of India
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Development

 

• In October 2025, Aspivix officially launched its Carevix device in the United States, initiating commercial rollout in Southern California and New York. The suction-based cervical stabilizer reduced pain and bleeding during gynecological procedures, marking a significant advancement in women’s healthcare.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the intrauterine devices market based on the below-mentioned segments: 

 

Global Intrauterine Devices Market, By Type

• Hormonal IUD
• Copper IUD

 

Global Intrauterine Devices Market, By Distribution Channel 

• Hospital
• Gynecology Clinics
• Community Health Care Centers
• Others

 

Global Intrauterine Devices Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  •  South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

 

1. What is the CAGR of the intrauterine devices market over the forecast period?

A: The global intrauterine devices market is projected to expand at a CAGR of 3.89% during the forecast period.

 

2. What is the market size of the intrauterine devices market?

A: The global intrauterine devices market size is estimated to grow from USD 4.6 billion in 2024 to USD 7.0 billion by 2035, at a CAGR of 3.89% during the forecast period 2025-2035.   

 

3. Which region holds the largest share of the intrauterine devices market?

A: Asia Pacific is anticipated to hold the largest share of the intrauterine devices market over the predicted timeframe.

 

4. Who are the top 10 companies operating in the global intrauterine devices market?

A: AbbVie Inc., Bayer AG, CooperSurgical Inc., DKT International, EUROGINE, S.L., Mona Lisa N.V., OCON Medical Ltd., Pregna International Limited., Prosan International BV, SMB Corporation of India, and Others.

 

5. What are the market trends in the intrauterine devices market?

A: The intrauterine devices market shows key trends which include rising demand for long-acting reversible contraception and product technological advancements and growing educational initiatives and government backing programs and worldwide improvement of women's reproductive health services access.